According to the announcement from Zhitong Finance APP, BOYA BIOLOGY (300294.SZ) stated that on May 16, 2025, the company's board of directors received written resignation reports from Liang Xiaoming and Liang Huacheng. Due to work changes, Liang Xiaoming applied to resign from the position of president and legal representative of the company, while Liang Huacheng applied to resign from the position of chief financial officer. After resigning from the positions of president and legal representative, Liang Xiaoming will continue to serve as a director of the company's eighth board of directors and a member of the strategy and ESG committee of the eighth board; Liang Huacheng will continue to serve as a director, vice president, and board secretary of the company after resigning from the chief financial officer position.

In accordance with relevant regulations and the actual operational management needs of the company, upon the nomination of the chairman, Vice President Ren Hui has been appointed as the company's president; upon the nomination of the president, Lin Qingsong has been newly appointed as the company's vice president, and director Pan Yuxuan has been appointed as the company's chief financial officer. The terms of the above personnel will last from the date of approval by this board meeting until the end of the current board's term. Given that Liang Xiaoming has resigned from the position of legal representative, in order to ensure the normal operation and management of the company, according to the relevant provisions of the Company Law and the Articles of Association, Ren Hui will serve as the legal representative of the company. The company will complete the relevant industrial and commercial change registration as soon as possible in accordance with legal procedures